Flowchart depicting the selection of participants and laboratory testing algorithm of the study on HBV and HCV prevalence and awareness of infection status within the HELIUS study, Amsterdam, the Netherlands, 2011-2014.
*1 individual was not tested for HBeAg due to insufficient blood.
Anti-HBc, antibodies to hepatitis B core antigen; anti-HBe, antibodies to HBe; anti-HBs, antibodies to HBsAg; anti-HCV, antibodies to HCV; HBeAg, hepatitis B-e-antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus.